Literature DB >> 8164817

Excessive muscular fatigue in the postpoliomyelitis syndrome.

K R Sharma1, J Kent-Braun, M A Mynhier, M W Weiner, R G Miller.   

Abstract

To investigate anterior tibial muscle fatigability and metabolism in postpoliomyelitis syndrome patients and controls, we performed measurements of force and relaxation time, as well as 31P magnetic resonance spectroscopy, during intermittent, low-intensity, isometric, voluntary exercise. Both maximum voluntary contraction and tetanic force declined significantly more during exercise and subsequently recovered less in patients compared with controls, indicating greater fatigue in patients. However, intracellular pH and phosphocreatine were not different in the two groups at rest or during exercise or recovery, suggesting that the greater fatigue of the patients was not due to an excessive change of metabolites. Moreover, the pre-exercise half-relaxation time of the tetanus was significantly prolonged in patients compared with controls, and the decline in tetanic force during exercise was linearly related to the half-relaxation time of tetanus, suggesting impaired calcium kinetics. Taken together, the findings of increased fatigability, delayed recovery, and prolonged half-relaxation time, without differences in metabolites, suggest that the fatigue in postpoliomyelitis syndrome may be due to impaired activation beyond the muscle membrane.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8164817     DOI: 10.1212/wnl.44.4.642

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  2 in total

Review 1.  Muscle high-energy phosphates in central nervous system disorders. The phosphorus MRS experience.

Authors:  Z Argov; N De Stefano; D L Arnold
Journal:  Ital J Neurol Sci       Date:  1997-12

2.  An observational cohort study on impact, dimensions and outcome of perceived fatigue in adult 5q-spinal muscular atrophy patients receiving nusinersen treatment.

Authors:  Camilla Binz; Olivia Schreiber-Katz; Susanne Petri; Alma Osmanovic; Mareike Kumpe; Gresa Ranxha; Hannah Siegler; Gary Wieselmann
Journal:  J Neurol       Date:  2020-10-07       Impact factor: 4.849

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.